Brokers have named CSL Limited (ASX:CSL) and these ASX shares as buys this week. Here’s why they are bullish on them…
The post Brokers name 3 ASX shares to buy right now appeared first on The Motley Fool Australia. –
Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
CSL Limited (ASX: CSL)
According to a note out of UBS, its analysts have retained their buy rating and $346.00 price target on this biotherapeutics giant’s shares. The broker has been looking at its plasma collection openings and is confident CSL will achieve its target of 20 to 30 new centres in FY 2021. It expects this to offset a portion of the decline it is facing with collections from COVID-19. And while these COVID headwinds are not easing, the broker notes that trading conditions are not as bad as they were at the peak of the pandemic. Overall, it appears comfortable CSL will achieve its forecasts this year. The CSL share price is trading at $294.51 this afternoon.
Healius Ltd (ASX: HLS)
Analysts at Credit Suisse have retained their outperform rating and $4.00 price target on this healthcare company’s shares. This follows the completion of its Medical Centre sale to private equity firm, BGH Capital. The broker believes that the company could return some of the proceeds to shareholders in the form of a special dividend and an increase in its payout ratio. It also sees potential for margin expansion in the near future thanks to favourable industry conditions. The Healius share price is changing hands for $3.62 on Friday.
Kogan.com Ltd (ASX: KGN)
Another note out of Credit Suisse reveals that its analysts have upgraded this ecommerce company’s shares to an outperform rating with an improved price target of $20.60. The broker made the move after Kogan announced the $122 million acquisition of online retailer Might Ape. It believes this is a quality acquisition and expects its to boost its private label offering. It also envisages notable synergies from the deal. The Kogan share price trading at $17.32 this afternoon.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of June 30th
- Why Cashrewards, Doctor Care Anywhere, Kogan, & Treasury Wine are pushing higher
- Why Flight Centre, Fortescue, Kogan, & Telix shares are racing higher
- Kogan (ASX:KGN) share price storms higher on $122m Mighty Ape acquisition
- After a record November, what’s next for ASX 200 shares?
- CBA (ASX:CBA) and the ASX banks just had an amazing month
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.